CME Group Inc. (NASDAQ:CME)‘s stock had its “buy” rating reissued by equities researchers at UBS AG in a research note issued to investors on Wednesday. They currently have a $135.00 target price on the financial services provider’s stock, up from their previous target price of $134.00. UBS AG’s price target would suggest a potential upside of 7.60% from the company’s current price.

A number of other research analysts also recently commented on CME. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a report on Thursday, August 3rd. Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 target price on shares of CME Group in a report on Friday, August 18th. Royal Bank Of Canada set a $135.00 target price on CME Group and gave the stock a “buy” rating in a report on Tuesday, August 1st. Jefferies Group LLC reaffirmed a “buy” rating and set a $128.00 target price on shares of CME Group in a report on Monday, July 10th. Finally, Citigroup Inc. began coverage on CME Group in a report on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. CME Group has a consensus rating of “Hold” and an average target price of $131.75.

Shares of CME Group (CME) traded up 2.25% during mid-day trading on Wednesday, hitting $128.28. 764,904 shares of the stock were exchanged. The stock has a market cap of $43.60 billion, a price-to-earnings ratio of 26.18 and a beta of 0.72. The company has a 50-day moving average price of $124.25 and a 200-day moving average price of $121.64. CME Group has a 12 month low of $98.95 and a 12 month high of $128.38.

CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. During the same quarter last year, the business posted $1.14 EPS. CME Group’s quarterly revenue was up 2.1% compared to the same quarter last year. Equities analysts expect that CME Group will post $4.81 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/06/ubs-ag-reaffirms-buy-rating-for-cme-group-inc-cme.html.

In related news, Chairman Terrence A. Duffy sold 21,815 shares of the firm’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total value of $2,702,660.35. Following the sale, the chairman now directly owns 110,711 shares in the company, valued at approximately $13,715,985.79. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, President Bryan T. Durkin sold 9,200 shares of the firm’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $125.13, for a total value of $1,151,196.00. Following the completion of the sale, the president now owns 70,938 shares in the company, valued at $8,876,471.94. The disclosure for this sale can be found here. Insiders have sold a total of 71,545 shares of company stock worth $8,944,496 over the last quarter. Insiders own 0.57% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. RMB Capital Management LLC increased its position in CME Group by 3.1% in the 1st quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock valued at $13,642,000 after acquiring an additional 3,501 shares during the period. Thrivent Financial For Lutherans increased its position in CME Group by 5.6% in the 1st quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock valued at $1,485,000 after acquiring an additional 660 shares during the period. Viking Fund Management LLC increased its position in CME Group by 3.6% in the 2nd quarter. Viking Fund Management LLC now owns 29,000 shares of the financial services provider’s stock valued at $3,632,000 after acquiring an additional 1,000 shares during the period. Janus Capital Management LLC increased its position in CME Group by 4.7% in the 1st quarter. Janus Capital Management LLC now owns 5,609,151 shares of the financial services provider’s stock valued at $666,367,000 after acquiring an additional 253,258 shares during the period. Finally, California Public Employees Retirement System increased its position in CME Group by 5.2% in the 1st quarter. California Public Employees Retirement System now owns 769,730 shares of the financial services provider’s stock valued at $91,444,000 after acquiring an additional 37,700 shares during the period. Hedge funds and other institutional investors own 82.66% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.